Number of patients | Pre-outbreak 2016q1-2020q1 | Post-outbreak 2020q2-2022q1 | Difference | ||||
---|---|---|---|---|---|---|---|
N | μ | N | μ | Δ (%) | p-value | ||
Number of practice visits | 2333 | 39,661 | 1.69 | 18,218 | 1.57 | -7.3% | < 0.001 |
Number of referrals | 2333 | 39,661 | 0.78 | 18,218 | 0.75 | -3.8% | 0.0121 |
Number of hospital admissions/referrals | 2333 | 39,661 | 0.02 | 18,218 | 0.01 | -13.3% | 0.1498 |
BMI (kg/m2) | 1612 | 10,540 | 30.4 | 8390 | 30.4 | 0.0% | 0.9706 |
RR-Systolic (mmHg) | 1024 | 3686 | 135.8 | 5682 | 139.3 | 2.6% | < 0.001 |
RR-Diastolic (mmHg) | 1022 | 3640 | 78.2 | 5672 | 79.7 | 1.9% | < 0.001 |
Number of diagnoses at practice visit (ICD-Chapter) | 2095 | 25,195 | 2.10 | 15,041 | 2.11 | 0.3% | 0.703 |
Diabetic-specific outcome | |||||||
Metabolic derailment (yes, %) | 2333 | 39,661 | 1.30 | 18,218 | 1.43 | 9.9% | 0.2111 |
HbA1c (%) | 1603 | 12,953 | 6.98 | 8012 | 7.08 | 1.5% | < 0.001 |